Renal association clinical practice guideline on the assessment of the potential kidney transplant recipient

Nephron - Clinical Practice

Volumn 118, Issue SUPPL. 1, 2011, Pages

  Dudley, Chris ^a   Harden, Paul ^b  

^a Richard Bright Renal Unit   (United Kingdom)

^b Oxford Kidney Unit   (United Kingdom)

Author keywords

access to transplantation; kidney transplant; potential transplant recipient

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; EVIDENCE BASED MEDICINE; GRAFT RECIPIENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MEDICAL AUDIT; MEDICAL SOCIETY; PATIENT ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SCREENING;

GREAT BRITAIN; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TRANSPLANTATION;

EID: 79955848788     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000328070     Document Type: Article

References (48)

1. Ravanan R, Udayaraj U, Ansell D et al. Variation between centres in access to renal transplantation in the UK; longitudinal cohort study. BMJ 2010;341:c3451
2. www.bts.org.uk
3. Le A., Wilson R, Douek K et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994;24(1): 65-71 (Pubitemid 24212978)
4. Humar A, Kerr AR, Ramcharan Tet al. Peri-operative cardiac morbidity in kidney transplant recipients: incidence and risk factors. Clin Transplant 2001;15:154-158 (Pubitemid 32487440)
5. Lentine K.L., Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005;16(2):496-506 (Pubitemid 41725147)
6. Patel RK, Mark PB, Johnston N et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-centre prospective observational study. Am J Transplant 2008;8:1673-1834
7. McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351(27): 2795-2804 (Pubitemid 40051903)
8. Kasiske BL, Malik MA, Herzog CA. Risk-stratified screening for ischemic heart disease in kidney transplant candidates. Transplantation 2005;80(6):815-820 (Pubitemid 41443765)
9. Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009;30:2769-2812
10. POISE Study Group, Devereaux PJ, Yang H, Yusuf S et al. Effect of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-1847
11. Bangalore S, Wetterslev J, Pranesh S et al. Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008;372: 1962-1976
12. Lindenauer PK., Pekow P, Wang K et al. Perioperative beta-blocker therapy and mortality after major non-cardiac surgery. N Engl J Med 2005;353(4):349-361 (Pubitemid 41132339)
13. Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;34:1789-1795
14. Fleischmann KE, Beckman JA, Buller CE et al. ACCF/AHA focused update on perioperative beta blockade. J Am Coll Cardiol 2009;54: 2102-2128
15. Mangano DT and the Multicenter Study of Peri-operative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347(17):1309-1317 (Pubitemid 35215321)
16. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of non-cardiac surgery. Circulation 2006;113(10):1361-1376 (Pubitemid 43739458)
17. Robertson AJ, Nargund V, Gray DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrol Dial Transplant 2000;15(11):1865-1881
18. Ozao-Choy J, Tammaro Y, FradisMet al. Clopidogrel and bleeding after general surgery procedures. Am Surg 2008;74:721-725
19. Bry W, Peddi V, Katznelson S et al. Kidney transplantation on Plavix: Feasible or foolhardy? Am J Transplant 2008;8(Suppl 2):516
20. Cosio FG, Falkenhain ME, Pesavento TE et al. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 1999;13(4):336-341 (Pubitemid 29392625)
21. Kasiske B and Klinger D. Cigarette smoking in renal transplant recipients. J Am Med Assoc 2000;11:753-759 (Pubitemid 30171885)
22. Sung RS, Althoen M, Howell TA et al. Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 2001;71(12): 1752-1757 (Pubitemid 32622486)
23. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343: 139-142
24. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. J Am Med Assoc 1999;281:72-76 (Pubitemid 29025103)
25. Glanton CW, Kao TC, Cruess D et al. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003;63(2):647-653 (Pubitemid 36126811)
26. Drafts HH, Anjum MR, Wynn JJ et al. The impact of pre-transplant obesity on renal transplant outcomes. Clin Transplant 1997;11:493-496 (Pubitemid 27460509)
27. Howard RJ, Thai VB, Patton PR et al. Obese kidney transplant recipients have good outcomes. Transplant Proc 2001;33:3420-3421 (Pubitemid 34042632)
28. Lynch RL, Ranney DN, Shijie C et al. Obesity, surgical site infection and outcome following renal transplantation. Ann Surgery 2009;250: 1014-1020
29. Yamamoto S, Hanley E, Hahn AB et al. The impact of obesity in renal transplantation: an analysis of paired cadaver kidneys. Clin Transplant 2002;16(4):252-256 (Pubitemid 34830841)
30. Johnson DW, Isbel NM, Brown AM et al. The effect of obesity on renal transplant outcomes. Transplantation 2002;74(5):675-681
31. Gore JL, Pham PT, Danovitch GM et al. Obesity and outcome following renal transplantation. Am J Transplant 2006;6:357-363 (Pubitemid 43382172)
32. Shahinian VB, Muirhead N, Jevnikar AM et al. Epstein-Barr virus seronegativity is a risk factor for late onset post-transplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation 2003;75:851-856 (Pubitemid 36373459)
33. Newstead C, Griffiths PD, O'Grady JG, Parameshwar JK. Guidelines for the prevention and management of cytomegalovirus after solid organ transplantation. 2nd Edition. British Transplantation Society 2004. ISBN 0-9542221-3-X
34. European Best Practice Guidelines (EBPG). Nephrol Dial Transplant 2000;15(7):9-11
35. Fornairon S, Pol S, Legendre C et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996;27:297-299 (Pubitemid 26251300)
36. Pereira BJ, Natov SN, Bouthot BA et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998;53:1374-1381 (Pubitemid 28316901)
37. European Best Practice Guidelines (EBPG). Nephrol Dial Transplant 2000;15(7):7-9
38. Abbott KC, Swanson SJ, Agodoa LY, Kimmel PL. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004;15:1633-1639 (Pubitemid 38679689)
39. Guidelines for Kidney Transplantation in Patients with HIV Disease 2005 www.bts.org.uk/standards
40. Agraharkar ML, Cinclair RD, Kuo YF et al. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int 2004;66:383-389 (Pubitemid 38870116)
41. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993;55:742-747 (Pubitemid 23122039)
42. Maisonneuvre P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999;10:93-99 (Pubitemid 29313142)
43. Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 2003;3:619-625 (Pubitemid 36612846)
44. Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol. 2001;12(2):394-402 (Pubitemid 32116384)
45. European Best Practice Guidelines (EBPG). Nephrol Dial Transplant 2000;15(7):11-20
46. http://www.bts.org.uk/transplantation/standards-and-guidelines
47. McCune TR, NylanderWA, van Buren DH et al. Colonic screening prior to renal transplantation and its impact on post-transplant colonic complications Clin Transplant. 1992;6(2):91-96
48. Troppman C, Papalois BE, Chiou A et al. Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era. J Am Coll Surg 1995;180:433-443